Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-08

Clinical Trial Update: Memantine Treatment Study of Pathological Gambling [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating memantine for pathological gambling has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)

Snippet

Sponsor: Yale University | Conditions: Pathological Gambling | Phase 2 | Status: COMPLETED | Results posted: 2013-04-08